Zynex (ZYXI) Competitors

Neuronetics (NASDAQ:STIM) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Do insiders & institutionals have more ownership in STIM or ZYXI?

53.6% of Neuronetics shares are held by institutional investors. Comparatively, 29.7% of Zynex shares are held by institutional investors. 8.7% of Neuronetics shares are held by company insiders. Comparatively, 49.3% of Zynex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has higher earnings & valuation, STIM or ZYXI?

Zynex has higher revenue and earnings than Neuronetics. Zynex is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$74.89M	3.23	-$43.71M	-$1.31	-2.79
Zynex	$192.35M	0.36	$2.99M	-$0.24	-9.63

Does the media favor STIM or ZYXI?

In the previous week, Zynex had 1 more articles in the media than Neuronetics. MarketBeat recorded 6 mentions for Zynex and 5 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.46 beat Zynex's score of -0.07 indicating that Neuronetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Zynex	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is STIM or ZYXI more profitable?

Zynex has a net margin of -4.30% compared to Neuronetics' net margin of -53.67%. Zynex's return on equity of -23.70% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-53.67%	-174.15%	-38.41%
Zynex	-4.30%	-23.70%	-6.23%

Do analysts recommend STIM or ZYXI?

Neuronetics presently has a consensus target price of $5.50, indicating a potential upside of 50.27%. Zynex has a consensus target price of $5.50, indicating a potential upside of 138.10%. Given Zynex's higher possible upside, analysts clearly believe Zynex is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Zynex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has more volatility and risk, STIM or ZYXI?

Neuronetics has a beta of 1.85, meaning that its stock price is 85% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

Summary

Zynex beats Neuronetics on 9 of the 16 factors compared between the two stocks.